This Biotech Stock Hits Buy Point After Earnings Burst

Blockhead
07 Mar

Multiple sclerosis biotech firm TG Therapeutics (TGTX) is Thursday's pick for IBD 50 Growth Stocks To Watch. TGTX stock jumped Thursday and broke out of an irregular base and is in a buy zone. Shares of TG Therapeutics bolted higher after the company topped fourth-quarter sales expectations with in-line earnings Monday. The IBD 50 and IBD Leaderboard component makes a…

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10